Hematology
| 3 min read
New compound could lead to accelerated regeneration of blood stem cells after chemotherapy or radiation
| 3 min read
Chimerix secures license to AML candidate with unique mechanism of action
| 1 min read
Agendia announces publication of study validating use of MammaPrint and BluePrint
| 3 min read
Amniotic fluid stem cells show promise in models of spina bifida
| 3 min read
Two enzymes indicted in inflammation and tumor growth in non-small cell lung carcinomas
| 6 min read
A roundup of instrumentation, software and other tools and technology news
| 3 min read
New alliance will use Mission Bio’s Tapestri Platform to investigate Onconova’s rigosertib
| 10+ min read
Unveiling the true promise of stem cell therapy, not the empty promises
| 3 min read
Thermo Fisher Scientific, Eli Lilly ink agreement to develop companion diagnostic for identifying patients who could benefit from Lilly's RET inhibitor, which recently posted strong Phase 1/2 data
| 2 min read
ASTX727 has been granted orphan drug designation for the treatment of myelodysplastic syndromes by the FDA
| 3 min read
DiscGenics receives FDA Fast Track designation for cell therapy for disc degeneration
| 4 min read
Karyopharm announces the publication of Xpovio (selinexor) Phase 2b STORM study results in the New England Journal of Medicine
